New pharmacological approaches for obesity management

Changes in Cardiovascular Risk Associated With Phentermine and Topiramate Extended-Release in Participants With Comorbidities and a Body Mass Index ≥27 kg/m2

(2013) Michael H. Davidson et al.   AMERICAN JOURNAL OF CARDIOLOGY

A history of drugs on the weight list

(2012) Elie Dolgin   NATURE MEDICINE

Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study

(2012) Patrick M. O'Neil et al.   Obesity

Appetite regulation and weight control: the role of gut hormones

(2012) B Perry et al.   Nutrition & Diabetes

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

(2011) W Timothy Garvey et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity

(2011) R. S. Padwal et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Topiramate-induced weight loss: A review

(2011) Alberto Verrotti et al.   EPILEPSY RESEARCH

Combination therapy with naltrexone and bupropion for obesity

(2011) Sonja K Billes et al.   EXPERT OPINION ON PHARMACOTHERAPY

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

(2011) Meredith C. Fidler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The medical care costs of obesity: An instrumental variables approach

(2011) John Cawley et al.   JOURNAL OF HEALTH ECONOMICS

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

(2011) Kishore M Gadde et al.   LANCET

Long-Term Persistence of Hormonal Adaptations to Weight Loss

(2011) Priya Sumithran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)

(2011) David B. Allison et al.   Obesity

Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials

(2011) C. K. Kramer et al.   Obesity Reviews

Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review

(2010) Philipp P. Lobmaier et al.   CNS Neuroscience & Therapeutics

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2010) Frank L Greenway et al.   LANCET

Hypothalamic opioid–Melanocortin appetitive balance and addictive craving

(2010) Albert Stuart Reece   MEDICAL HYPOTHESES

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

(2010) Thomas A. Wadden et al.   Obesity

Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects

(2009) Rochelle Goldsmith et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity

(2009) Raymond A Plodkowski et al.   EXPERT OPINION ON PHARMACOTHERAPY

Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo

(2009) Frank L. Greenway et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Topiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register

(2008) S. Hunt et al.   NEUROLOGY

Rational Design of a Combination Medication for the Treatment of Obesity

(2008) Frank L. Greenway et al.   Obesity